These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 18651570)
21. VSV-G pseudotyped, MuLV-based, semi-replication-competent retrovirus for cancer treatment. Qiao J; Moreno J; Sanchez-Perez L; Kottke T; Thompson J; Caruso M; Diaz RM; Vile R Gene Ther; 2006 Oct; 13(20):1457-70. PubMed ID: 16724095 [TBL] [Abstract][Full Text] [Related]
22. Combination gene therapy of lung cancer with conditionally replicating adenovirus and adenovirus-herpes simplex virus thymidine kinase. Oh JY; Park MY; Kim DR; Lee JH; Shim SH; Chung JH; Yoon HI; Lee JH; Sung MW; Kim YS; Lee CT Int J Mol Med; 2010 Mar; 25(3):369-76. PubMed ID: 20127041 [TBL] [Abstract][Full Text] [Related]
23. An armed oncolytic herpes simplex virus expressing thrombospondin-1 has an enhanced in vivo antitumor effect against human gastric cancer. Tsuji T; Nakamori M; Iwahashi M; Nakamura M; Ojima T; Iida T; Katsuda M; Hayata K; Ino Y; Todo T; Yamaue H Int J Cancer; 2013 Jan; 132(2):485-94. PubMed ID: 22729516 [TBL] [Abstract][Full Text] [Related]
24. Herpes simplex virus delivery to orthotopic rectal carcinoma results in an efficient and selective antitumor effect. Kolodkin-Gal D; Edden Y; Hartshtark Z; Ilan L; Khalaileh A; Pikarsky AJ; Pikarsky E; Rabkin SD; Panet A; Zamir G Gene Ther; 2009 Jul; 16(7):905-15. PubMed ID: 19440231 [TBL] [Abstract][Full Text] [Related]
25. Targeted radiotherapy for prostate cancer with an oncolytic adenovirus coding for human sodium iodide symporter. Hakkarainen T; Rajecki M; Sarparanta M; Tenhunen M; Airaksinen AJ; Desmond RA; Kairemo K; Hemminki A Clin Cancer Res; 2009 Sep; 15(17):5396-403. PubMed ID: 19706820 [TBL] [Abstract][Full Text] [Related]
26. [Construction of a new oncolytic virus oHSV2hGM-CSF and its anti-tumor effects]. Shi GL; Zhuang XF; Han XP; Li J; Zhang Y; Zhang SR; Liu BL Zhonghua Zhong Liu Za Zhi; 2012 Feb; 34(2):89-95. PubMed ID: 22780924 [TBL] [Abstract][Full Text] [Related]
28. Systemic efficacy of oncolytic adenoviruses in imagable orthotopic models of hormone refractory metastatic breast cancer. Ranki T; Särkioja M; Hakkarainen T; von Smitten K; Kanerva A; Hemminki A Int J Cancer; 2007 Jul; 121(1):165-74. PubMed ID: 17315187 [TBL] [Abstract][Full Text] [Related]
29. MicroRNA regulation of oncolytic herpes simplex virus-1 for selective killing of prostate cancer cells. Lee CY; Rennie PS; Jia WW Clin Cancer Res; 2009 Aug; 15(16):5126-35. PubMed ID: 19671871 [TBL] [Abstract][Full Text] [Related]
30. Treatment of malignant effusion by oncolytic virotherapy in an experimental subcutaneous xenograft model of lung cancer. Weibel S; Hofmann E; Basse-Luesebrink TC; Donat U; Seubert C; Adelfinger M; Gnamlin P; Kober C; Frentzen A; Gentschev I; Jakob PM; Szalay AA J Transl Med; 2013 May; 11():106. PubMed ID: 23635329 [TBL] [Abstract][Full Text] [Related]
31. A novel translational approach for human malignant pleural mesothelioma: heparanase-assisted dual virotherapy. Watanabe Y; Kojima T; Kagawa S; Uno F; Hashimoto Y; Kyo S; Mizuguchi H; Tanaka N; Kawamura H; Ichimaru D; Urata Y; Fujiwara T Oncogene; 2010 Feb; 29(8):1145-54. PubMed ID: 19935710 [TBL] [Abstract][Full Text] [Related]
32. A novel Ad5/11 chimeric oncolytic adenovirus for improved glioma therapy. Li X; Mao Q; Wang D; Xia H Int J Oncol; 2012 Dec; 41(6):2159-65. PubMed ID: 23117867 [TBL] [Abstract][Full Text] [Related]
33. Virotherapy with a Semliki Forest Virus-Based Vector Encoding IL12 Synergizes with PD-1/PD-L1 Blockade. Quetglas JI; Labiano S; Aznar MÁ; Bolaños E; Azpilikueta A; Rodriguez I; Casales E; Sánchez-Paulete AR; Segura V; Smerdou C; Melero I Cancer Immunol Res; 2015 May; 3(5):449-54. PubMed ID: 25691326 [TBL] [Abstract][Full Text] [Related]
34. Use of an oncolytic vaccinia virus for the treatment of canine breast cancer in nude mice: preclinical development of a therapeutic agent. Gentschev I; Stritzker J; Hofmann E; Weibel S; Yu YA; Chen N; Zhang Q; Bullerdiek J; Nolte I; Szalay AA Cancer Gene Ther; 2009 Apr; 16(4):320-8. PubMed ID: 18949014 [TBL] [Abstract][Full Text] [Related]
35. Histone deacetylase inhibitor FR901228 enhances the antitumor effect of telomerase-specific replication-selective adenoviral agent OBP-301 in human lung cancer cells. Watanabe T; Hioki M; Fujiwara T; Nishizaki M; Kagawa S; Taki M; Kishimoto H; Endo Y; Urata Y; Tanaka N; Fujiwara T Exp Cell Res; 2006 Feb; 312(3):256-65. PubMed ID: 16356494 [TBL] [Abstract][Full Text] [Related]
36. Oncolytic virus therapy for pancreatic cancer using the adenovirus library displaying random peptides on the fiber knob. Nishimoto T; Yoshida K; Miura Y; Kobayashi A; Hara H; Ohnami S; Kurisu K; Yoshida T; Aoki K Gene Ther; 2009 May; 16(5):669-80. PubMed ID: 19225547 [TBL] [Abstract][Full Text] [Related]
37. A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo. Li B; Liu X; Fan J; Qi R; Bo L; Gu J; Qian Q; Qian C; Liu X J Gene Med; 2006 Oct; 8(10):1232-42. PubMed ID: 16900558 [TBL] [Abstract][Full Text] [Related]
38. Replicating retroviral vectors for oncolytic virotherapy of experimental hepatocellular carcinoma. Lu YC; Chen YJ; Yu YR; Lai YH; Cheng JC; Li YF; Shen CH; Tai CK Oncol Rep; 2012 Jul; 28(1):21-6. PubMed ID: 22552490 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of retinoblastoma in vitro and in vivo with conditionally replicating oncolytic adenovirus H101. Song X; Zhou Y; Jia R; Xu X; Wang H; Hu J; Ge S; Fan X Invest Ophthalmol Vis Sci; 2010 May; 51(5):2626-35. PubMed ID: 20007825 [TBL] [Abstract][Full Text] [Related]
40. Neoadjuvant administration of Semliki Forest virus expressing interleukin-12 combined with attenuated Salmonella eradicates breast cancer metastasis and achieves long-term survival in immunocompetent mice. Kramer MG; Masner M; Casales E; Moreno M; Smerdou C; Chabalgoity JA BMC Cancer; 2015 Sep; 15():620. PubMed ID: 26347489 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]